Nucleoside analog monotherapy is the current standard of care for many patients.

Extended medication with dual antiplatelet therapy was required because dose reduction to aspirin monotherapy worsened symptoms.

Minocycline monotherapy is recommended for patients without poor prognostic features, with low disease activity, and with short disease duration.